Is there a role for microsampling in antibiotic pharmacokinetic studies?

References

• Roberts JA, De Waele JJ, Dimopoulos G, et al. DALI: defining antibiotic levels in intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis. 2012;12:7.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14:498–509.
   PubMed Web of Science ®Google Scholar
• Howie SRC. Blood sample volumes in child health research: review of safe limits; 2010. January 2011.
   Google Scholar
• Svensson LD, Sennbro CJ, Svanstrom C, et al. Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod. Bioanalysis. 2015;7:179–191.
   PubMed Web of Science ®Google Scholar
• Yuan L, Schuster A, Shen JX, et al. Dried blood spot analysis without dilution: application to the LC-MS/MS determination of BMS-986001 in rat dried blood spot. J Chromatogr B-Anal Technol Biomed Life Sci. 2015;1002:201–209.
   PubMed Web of Science ®Google Scholar
• Milosheska D, Grabnar I, Vovk T. Dried blood spots for monitoring and individualization of antiepileptic drug treatment. Eur J Pharm Sci. 2015;75:25–39.
   PubMed Web of Science ®Google Scholar
• Sistik P, Urinovska R, Brozmanova H, et al. Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication. Biomed Chromatogr. 2016;30:217–224.
   PubMed Web of Science ®Google Scholar
• Siebenhaar M, Kullmer K, Fernandes NMD, et al. Personalized monitoring of therapeutic salicylic acid in dried blood spots using a three-layer setup and desorption electrospray ionization mass spectrometry. Anal Bioanal Chem. 2015;407:7229–7238.
   PubMed Web of Science ®Google Scholar
• Antunes MV, Raymundo S, Wagner SC, et al. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application. Bioanalysis. 2015;7:2105–2117.
   PubMed Web of Science ®Google Scholar
• Matsuda KC, Hall C, Baker-Lee C, et al. Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling. Bioanalysis. 2013;5:1979–1990.
   PubMed Web of Science ®Google Scholar
• Kaendler K, Warren A, Lloyd P, et al. Evaluation of dried blood spots for the quantification of therapeutic monoclonal antibodies and detection of anti-drug antibodies. Bioanalysis. 2013;5:613–622.
   PubMed Web of Science ®Google Scholar
• Missler U, Gutekunst R, Wood WG. Thyroglobulin is a more sensitive indicator of iodine deficiency than thyrotropin: development and evaluation of dry blood spot assays for thyrotropin and thyroglobulin in iodine-deficient geographical areas. Eur J Clin Chem Clin Biochem. 1994;32:137–143.
   PubMedGoogle Scholar
• Burns D, Brunner L, Rajendran S, et al. Validation of a ligand binding assay using dried blood spot sampling. Aaps J. 2013;15:123–131.
   PubMed Web of Science ®Google Scholar
• Li FM, Ploch S, Fast D, et al. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection. J Mass Spectrom. 2012;47:655–667.
   PubMed Web of Science ®Google Scholar
• Jonsson O, Villar RP, Nilsson LB, et al. Validation of a bioanalytical method using capillary microsampling of 8 µl plasma samples: application to a toxicokinetic study in mice. Bioanalysis. 2012;4:1989–1998.
   PubMed Web of Science ®Google Scholar
• Caron A, Lelong C, Pascual MH, et al. Miniaturized blood sampling techniques to benefit reduction in mice and refinement in nonhuman primates: applications to bioanalysis in toxicity studies with antibody-drug conjugates. J Amer Assoc Lab Anim Sci. 2015;54:145–152.
   PubMed Web of Science ®Google Scholar
• Stove C, Spooner N. DBS and beyond. Bioanalysis. 2015;7:1961–1962.
   PubMed Web of Science ®Google Scholar
• Welling PG. Differences between pharmacokinetics and toxicokinetics. Toxicol Pathol. 1995;23:143–147.
   PubMed Web of Science ®Google Scholar
• Chapman K, Chivers S, Gliddon D, et al. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discov Today. 2014;19:528–532.
   PubMed Web of Science ®Google Scholar
• Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001;21:15–23.
   PubMed Web of Science ®Google Scholar
• Guhad F. Introduction to the 3Rs (refinement, reduction and replacement). Contemp Top Lab Anim Sci. 2005;44:58–59.
   PubMedGoogle Scholar
• Chapman K, Burnett J, Corvaro M, et al. Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite. Bioanalysis. 2014;6:2965–2968.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Good laboratory practice for nonclinical laboratory studies. Silver Spring (MD): US Department of Health and Human Services. ed; 2015 Aug 21.
   Google Scholar
• Himebauch AS, Zuppa A. Methods for pharmacokinetic analysis in young children. Expert Opin Drug Metab Toxicol. 2014;10:497–509.
   PubMed Web of Science ®Google Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology - drug disposition, action, and therapy in infants and children. New England J Med. 2003;349:1157–1167.
   PubMed Web of Science ®Google Scholar
• Olsson J, Kimland E, Pettersson S, et al. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care–a nationwide study. Acta Paediatr. 2011;100:1272–1275.
   PubMed Web of Science ®Google Scholar
• Sisson TRC, Lund CJ, Whalen LE, et al. The blood volume of infants. I. The full-term infant in the first year of life. J Pediatr. 1959;55:163–179.
   PubMed Web of Science ®Google Scholar
• Sisson TRC, Whalen LE, Telek A. The blood volume of infants. II. The premature infant during the first year of life. J Pediatr. 1959;55:430–446.
   PubMed Web of Science ®Google Scholar
• Office of the Assistant Secretary for Health. OHRP expedited review categories (1998). U.S. Department of Health & Human Services, ed. Rockville (MD): HHS.gov; 1998.
   Google Scholar
• Owens RC Jr., Ambrose PG. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era. Diagn Microbiol Infect Dis. 2007;57:77S–83S.
   PubMed Web of Science ®Google Scholar
• Tanna S, Lawson G. Self-sampling and quantitative analysis of DBS: can it shift the balance in over-burdened healthcare systems? Bioanalysis. 2015;7:1963–1966.
   PubMed Web of Science ®Google Scholar
• Lemaitre F, Hasni N, Leprince P, et al. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19:772.
   Web of Science ®Google Scholar
• Sime FB, Roberts MS, Tiong IS, et al. Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial. J Antimicrob Chemother. 2015;70:2369–2375.
   PubMed Web of Science ®Google Scholar
• Fournier A, Eggimann P, Pagani J-L, et al. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients. Burns. 2015;41:956–968.
   PubMed Web of Science ®Google Scholar
• Li Q, Cao D, Huang Y, et al. Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots. Biomed Chromatogr. 2013;27:327–334.
   PubMed Web of Science ®Google Scholar
• Koop DR, Bleyle LA, Munar M, et al. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. J Chromatogr B-Anal Technol Biomed Life Sci. 2013;926:54–61.
   PubMed Web of Science ®Google Scholar
• Shah NM, Hawwa AF, Millership JS, et al. A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. J Chromatogr B-Anal Technol Biomed Life Sci. 2013;923:65–73.
   PubMed Web of Science ®Google Scholar
• Deglon J, Thomas A, Cataldo A, et al. On-line desorption of dried blood spot: a novel approach for the direct LC/MS analysis of micro-whole blood samples. J Pharm Biomed Anal. 2009;49:1034–1039.
   PubMed Web of Science ®Google Scholar
• Rowland M, Tozer TN. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. 4th ed. Philadelphia: Lippincott William & Wilkins; 2011.
   Google Scholar
• Kilbaugh TJ, Himebauch AS, Zaoutis T, et al. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery. Pediatr Anesth. 2015;25:1111–1119.
   PubMed Web of Science ®Google Scholar
• Schleibinger M, Steinbach CL, Topper C, et al. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients. Br J Clin Pharmacol. 2015;80:525–533.
   PubMed Web of Science ®Google Scholar
• Reichel C, Von Falkenhausen M, Brockmeier D, et al. Characterization of cyclosporine a uptake in human erythrocytes. Eur J Clin Pharmacol. 1994;46:417–419.
   PubMed Web of Science ®Google Scholar
• Hinderling PH. Kinetics of partitioning and binding of digoxin and its analogues in the subcompartments of blood. J Pharm Sci. 1984;73:1042–1053.
   PubMed Web of Science ®Google Scholar
• Rowland M, Emmons G. Use of dried blood spots in drug development: pharmacokinetic considerations. Aaps J. 2010;12:290–293.
   PubMed Web of Science ®Google Scholar
• Shin WG, Lee MG, Lee MH, et al. Pharmacokinetics of drugs in blood VII: unusual distribution and blood storage effect of vancomycin. Biopharm Drug Dispos. 1992;13:305–310.
   PubMed Web of Science ®Google Scholar
• Lee MG, Chen M-L, Huang S-M, et al. Pharmacokinetics of drugs in blood I. Unusual distribution of gentamicin. Biopharm Drug Dispos. 1981;2:89–97.
   PubMed Web of Science ®Google Scholar
• Zeitlinger MA, Sauermann R, Traunmuller F, et al. Impact of plasma protein binding on antimicrobial activity using time-killing curves. J Antimicrob Chemother. 2004;54:876–880.
   PubMed Web of Science ®Google Scholar
• Parker SL, Lipman J, Dimopoulos G, et al. A validated method for the quantification of fosfomycin on dried plasma spots by HPLC-MS/MS: application to a pilot pharmacokinetic study in humans. J Pharm Biomed Anal. 2015;115:509–514.
   PubMed Web of Science ®Google Scholar
• Parker SL, Roberts JA, Lipman J, et al. Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling (VAMS). Bioanalysis. 2015;7:2585–2595.
   PubMed Web of Science ®Google Scholar
• Holtzinger C, Szelag E, DuBois JA, et al. Evaluation of a new POCT bedside glucose meter and strip with hematocrit and interference corrections. Point Care: J Near-Patient Test Technol. 2008;7:1–6.
   Google Scholar
• Tirimacco R, Siew L, Simpson PA, et al. Understanding the hematocrit effect on glucose testing using popular point-of-care testing devices. Point of Care: J Near-Patient Test & Technol. 2014;13:128–131.
   Google Scholar
• Petersen JR, Graves DF, Tacker DH, et al. Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clinica Chimica Acta. 2008;396:10–13.
   PubMed Web of Science ®Google Scholar
• Ellis MF, Benjamin K, Cornell M, et al. Suitability of capillary blood glucose analysis in patients receiving vasopressors. Am J Crit Care. 2013;22:423–429.
   PubMed Web of Science ®Google Scholar
• Soto M, Pham R, Almon V, et al. Evaluation of matrix microsampling methods for therapeutic drug candidate quantification in discovery-stage rodent pharmacokinetic studies. Bioanalysis. 2014;6:2135–2146.
   PubMed Web of Science ®Google Scholar
• Bowen CL, Licea-Perez H, Karlinsey MZ, et al. A novel approach to capillary plasma microsampling for quantitative bioanalysis. Bioanalysis. 2013;5:1131–1135.
   PubMed Web of Science ®Google Scholar
• Spreadborough MJ, Day J, Jackson-Addie K, et al. Bioanalytical implementation of plasma capillary microsampling: small hurdles, large gains. Bioanalysis. 2013;5:1485–1489.
   PubMed Web of Science ®Google Scholar
• Luo Y, Korfmacher W, Ho S, et al. Evaluation of two blood microsampling approaches for drug discovery PK studies in rats. Bioanalysis. 2015;7:2345–2359.
   PubMed Web of Science ®Google Scholar
• Slazyk WE, Phillips DL, Therrell BL, et al. Effect of lot-to-lot variability in filter paper on the quantification of thyroxin, thyrotropin, and phenylalanine in dried-blood specimens. Clin Chem. 1988;34:53–58.
   PubMed Web of Science ®Google Scholar
• Barfield M, Spooner N, Lad R, et al. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. J Chromatogr B-Anal Technol Biomed Life Sci. 2008;870:32–37.
   PubMed Web of Science ®Google Scholar
• Liang XR, Li YH, Barfield M, et al. Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. J Chromatogr B-Anal Technol Biomed Life Sci. 2009;877:799–806.
   PubMed Web of Science ®Google Scholar
• Clark GT, Haynes JJ, Bayliss MAJ, et al. Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice. Bioanalysis. 2010;2:1477–1488.
   PubMed Web of Science ®Google Scholar
• Swales JG, Gallagher RT, Denn M, et al. Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometry. J Pharm Biomed Anal. 2011;55:544–551.
   PubMed Web of Science ®Google Scholar
• Lawson AJ, Bernstone L, Hall SK. Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit. J Med Screen. 2016;23:7–16.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Baron J-F, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc. 2002;288:1499–1507.
   PubMed Web of Science ®Google Scholar
• Timmerman P, White S, Cobb Z, et al. Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium. Bioanalysis. 2013;5:2129–2136.
   PubMed Web of Science ®Google Scholar
• Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis. 2010;2:1385–1395.
   PubMed Web of Science ®Google Scholar
• Cobb Z, De Vries R, Spooner N, et al. In-depth study of homogeneity in DBS using two different techniques: results from the EBF DBS-microsampling consortium. Bioanalysis. 2013;5:2161–2169.
   PubMed Web of Science ®Google Scholar
• Jager NGL, Rosing H, Schellens JHM, et al. Determination of tamoxifen and endoxifen in dried blood spots using LC-MS/MS and the effect of coated DBS cards on recovery and matrix effects. Bioanalysis. 2014;6:2999–3009.
   PubMed Web of Science ®Google Scholar
• de Vries R, Barfield M, van de Merbel N, et al. The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium. Bioanalysis. 2013;5:2147–2160.
   PubMed Web of Science ®Google Scholar
• De Kesel PMM, Lambert WE, Stove CP. Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study. Anal Chim Acta. 2015;881:65–73.
   PubMed Web of Science ®Google Scholar
• Miao ZX, Farnham JG, Hanson G, et al. Bioanalysis of emixustat (ACU-4429) in whole blood collected with volumetric absorptive microsampling by LC-MS/MS. Bioanalysis. 2015;7:2071–2083.
   PubMed Web of Science ®Google Scholar
• Denniff P, Spooner N. Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal Chem. 2014;86:8489–8495.
   PubMed Web of Science ®Google Scholar
• Spooner N, Denniff P, Michielsen L, et al. A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. Bioanalysis. 2015;7:653–659.
   PubMed Web of Science ®Google Scholar
• Phenomenex. Mitra microsampling device BR22720914_W. Phenomenex USA International Department; 2014
   Google Scholar
• Shimadzu. Noviplex cards; 2016 [ cited 25 Jan 2016]. Available from: https://shimadzu.com.au/noviplex-cards
   Google Scholar
• Sturm R, Henion J, Abbott R, et al. Novel membrane devices and their potential utility in blood sample collection prior to analysis of dried plasma spots. Bioanalysis. 2015;7:1987–2002.
   PubMed Web of Science ®Google Scholar
• Li YY, Henion J, Abbott R, et al. The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood. Rapid Commun Mass Spectrom. 2012;26:1208–1212.
   PubMed Web of Science ®Google Scholar
• Kim J-H, Woenker T, Adamec J, et al. Simple, miniaturized blood plasma extraction method. Anal Chem. 2013;85:11501–11508.
   PubMed Web of Science ®Google Scholar
• Farhadi K, Hatami M, Matin AA. Microextraction techniques in therapeutic drug monitoring. Biomed Chromatogr. 2012;26:972–989.
   PubMed Web of Science ®Google Scholar
• Schubert JK, Miekisch W, Fuchs P, et al. Determination of antibiotic drug concentrations in circulating human blood by means of solid phase micro-extraction. Clinica Chimica Acta. 2007;386:57–62.
   PubMed Web of Science ®Google Scholar
• Prosen H, Zupancic-Kralj L. Solid-phase microextraction. Trac-Trends Anal Chem. 1999;18:272–282.
   Web of Science ®Google Scholar
• Wasowicz M, Jerath A, Bojko B, et al. Use of a novel technique, solid phase microextraction, to measure tranexamic acid in patients undergoing cardiac surgery. Can J Anesth. 2012;59:14–20.
   PubMed Web of Science ®Google Scholar
• Reyes-Garces N, Bojko B, Hein D, et al. Solid phase microextraction devices prepared on plastic support as potential single-use samplers for bioanalytical applications. Anal Chem. 2015;87:9722–9730.
   PubMed Web of Science ®Google Scholar
• Carreño Balcázar JS, Meesters RJW. Bioanalytical comparison between dried urine spots and liquid urine bioassays used for the quantitative analysis of urinary creatinine concentrations. Bioanalysis. 2014;6:2803–2814.
   PubMed Web of Science ®Google Scholar
• Olagunju A, Bolaji OO, Amara A, et al. Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. J Antimicrob Chemother. 2015;70:555–561.
   PubMed Web of Science ®Google Scholar
• Henion J, Oliveira RV, Chace DH. Microsample analyses via DBS: challenges and opportunities. Bioanalysis. 2013;5:2547–2565.
   PubMed Web of Science ®Google Scholar
• Li FM, Ploch S. Will ‘green’ aspects of dried blood spot sampling accelerate its implementation and acceptance in the pharmaceutical industry? Bioanalysis. 2012;4:1259–1261.
   PubMed Web of Science ®Google Scholar
• Timmerman P, White S, Cobb Z, et al. European bioanalysis forum continued plans to support liquid microsampling. Bioanalysis. 2014;6:1897–1900.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Guidance for industry bioanalytical method validation. Rockville (MD): Services UDoHaH, ed.; 2013.
   Google Scholar
• Page-Sharp M, Nunn T, Salman S, et al. Validation and application of a dried blood spot ceftriaxone assay. Antimicrob Agents Chemother. 2016;60:14–23.
   PubMed Web of Science ®Google Scholar
• Dailly E, Bouquie R, Deslandes G, et al. A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. J Chromatogr B-Anal Technol Biomed Life Sci. 2011;879:1137–1142.
   PubMed Web of Science ®Google Scholar
• la Marca G, Giocaliere E, Villanelli F, et al. Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots. J Pharm Biomed Anal. 2012;61:108–113.
   PubMed Web of Science ®Google Scholar
• Majumdar AK, Musson DG, Birk KL, et al. Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrob Agents Chemother. 2002;46:3506–3511.
   PubMed Web of Science ®Google Scholar
• Barco S, Risso FM, Bruschettini M, et al. A validated LC-MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot. Bioanalysis. 2014;6:2795–2802.
   PubMed Web of Science ®Google Scholar
• Yu H-C, Pan C-W, Xie Q-P, et al. Simultaneous determination of tedizolid and linezolid in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study. J Chromatogr B-Anal Technol Biomed Life Sci. 2016;1011:94–98.
   PubMed Web of Science ®Google Scholar
• la Marca G, Villanelli F, Malvagia S, et al. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot. J Pharm Biomed Anal. 2012;67–68:86–91.
   PubMed Web of Science ®Google Scholar
• Baietto L, D’Avolio A, Ariaudo A, et al. Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. J Chromatogr B-Anal Technol Biomed Life Sci. 2013;936:42–47.
   PubMed Web of Science ®Google Scholar
• Olszowy P, Szultka M, Nowaczyk J, et al. A new way of solid-phase microextraction fibers preparation for selected antibiotic drug determination by HPLC-MS. J Chromatogr B-Anal Technol Biomed Life Sci. 2011;879:2542–2548.
   PubMed Web of Science ®Google Scholar
• Wiskirchen DE, Shepard A, Kuti JL, et al. Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis. Antimicrob Agents Chemother. 2011;55:4170–4175.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Desta KT, Eum SY, et al. Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: potential application as therapeutic drug monitoring tool in medical diagnosis. J Chromatogr B-Anal Technol Biomed Life Sci. 2016;1009–1010:138–143.
   PubMed Web of Science ®Google Scholar
• Parker SL, Frantzeskaki F, Wallis SC, et al. Population pharmacokinetics of fosfomycin in critically Ill patients. Antimicrob Agents Chemother. 2015;59:6471–6476.
   PubMed Web of Science ®Google Scholar
• Ewles MF, Turpin PE, Goodwin L, et al. Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS. Biomed Chromatogr. 2011;25:995–1002.
   PubMed Web of Science ®Google Scholar
• Kenny MT, Brackman MA, Dulworth JK. Bioassay quantitation of ramoplanin in human and in nonprimate sera. Diagn Microbiol Infect Dis. 1994;18:117–119.
   PubMed Web of Science ®Google Scholar
• Baietto L, D’Avolio A, Pace S, et al. Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. J Pharm Biomed Anal. 2014;88:66–70.
   PubMed Web of Science ®Google Scholar
• Lee BL, Sachdeva M, Chambers HF. Effect of protein-binding of daptomycin on MIC and antibacterial activity. Antimicrob Agents Chemother. 1991;35:2505–2508.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Guideline on bioanlaytical method validation. London (UK): Use CfMPfH, ed.; 2011.
   Google Scholar
• Food and Drug Administration. Guidance for industry bioanalytical method validation. Rockville (MD): Services UDoHaH, ed.; 2001.
   Google Scholar
• Wickremsinhe ER, Huang NH, Abdul BG, et al. Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles. Bioanalysis. 2013;5:159–170.
   PubMed Web of Science ®Google Scholar
• Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part I). Clin Pharmacokinet. 1989;17:175–199.
   PubMed Web of Science ®Google Scholar
• Vroom VH. Leadership and the decision-making process. Organ Dyn. 2000;28:82–94.
   Web of Science ®Google Scholar